Clinical trialNCT06968845RecruitingPhase 2Interventional

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

SponsorRein TherapeuticsEnrollment120Idiopathic Pulmonary Fibrosis (IPF)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Westmead Hospital
Westmead, New South Wales, Australia
Laura Glenn, MD, PhD
Recruiting
Launceston Respiratory and Sleep Centre
Launceston, Tasmania, Australia
Collin Chia, MD
Recruiting

Poland

Instytut Gruzlicy I Chrob Pluc
Warsaw, Poland, Poland
Katarzyna Lewandowska, MD
Recruiting
Salus Aegroti Praktyka Lekarska Dr N. Med. Grzegorz Gąsior
Sosnowiec, Silesian Voivodeship, Poland
Grzegorz Gasior, MD, PhD
Recruiting

United Kingdom

Royal Papworth Hospital
Trumpington, Cambridge, United Kingdom
Helen Parfrey, MD
Recruiting
Royal Devon and Exeter Hospital
Exeter, Devon, United Kingdom
Michael Gibbons, MD
Recruiting
Royal Infirmary of Edinburgh
Edinburgh, Scotland, United Kingdom
Manjit Cartlidge, MD
Recruiting
Royal Brompton Hospital
London, United Kingdom
Philip Molyneaux, MD
Recruiting

United States

Uab Lung Health Center
Birmingham, Alabama, United States
Tejaswini Kulkarni, MD
Recruiting
Cedars Sinai Medical Center
Los Angeles, California, United States
Tanzira Zaman, MD
Recruiting
Paradigm Clinical Research Centers, Llc
San Diego, California, United States
Daniel Jones, MD
Recruiting
National Jewish Health
Denver, Colorado, United States
Evans Fernandez Perez, MD
Recruiting
Yale University School of Medicine
New Haven, Connecticut, United States
Danielle Antin-Ozerkis, MD
Recruiting
Cleveland Clinic Florida
Weston, Florida, United States
David Zisman, MD
Recruiting
Henry Ford Health
Detroit, Michigan, United States
Asif M. Abdul Hameed, MD
Recruiting
the Lung Research Center, Llc
Chesterfield, Missouri, United States
Neil Ettinger, MD
Recruiting
University of Kansas Medical Center
Kansas City, Missouri, United States
Mark Hamblin, MD
Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Jason Lobo, MD
Recruiting
Medical University of South Carolina
Charleston, South Carolina, United States
Timothy Whelan, MD
Recruiting
El Paso Pulmonary Association
El Paso, Texas, United States
Carlo M. Hatem, MD
Recruiting
University of Utah
Salt Lake City, Utah, United States
Mary Beth Scholand, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Feb 2026
Primary completion: 30 Sept 2027
Completion: 31 Dec 2027
Last update posted: 6 Jul 2026
Registered enrollment: 120
Registry id: NCT06968845

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.